Elan Eisenmesser
Concepts (371)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pneumoniae | 5 | 2025 | 169 | 2.620 |
Why?
| | Cyclophilin A | 13 | 2017 | 26 | 2.510 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 3 | 2024 | 26 | 2.160 |
Why?
| | Catalytic Domain | 11 | 2025 | 207 | 1.830 |
Why?
| | Basigin | 5 | 2017 | 25 | 1.690 |
Why?
| | Cyclophilins | 7 | 2023 | 40 | 1.580 |
Why?
| | Models, Molecular | 28 | 2025 | 1570 | 1.560 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 22 | 2020 | 340 | 1.530 |
Why?
| | Interleukin-1 | 9 | 2024 | 965 | 1.380 |
Why?
| | Serine Endopeptidases | 3 | 2025 | 123 | 1.380 |
Why?
| | Virulence Factors | 3 | 2022 | 167 | 1.340 |
Why?
| | Protein Conformation | 18 | 2025 | 934 | 1.260 |
Why?
| | Bacterial Proteins | 7 | 2025 | 879 | 1.250 |
Why?
| | Thermodynamics | 3 | 2020 | 407 | 0.960 |
Why?
| | Serine Proteases | 1 | 2025 | 19 | 0.940 |
Why?
| | Mutation | 6 | 2025 | 3958 | 0.850 |
Why?
| | Protein Binding | 18 | 2024 | 2224 | 0.820 |
Why?
| | Coenzymes | 2 | 2024 | 19 | 0.810 |
Why?
| | Evolution, Molecular | 2 | 2024 | 493 | 0.810 |
Why?
| | Molecular Dynamics Simulation | 5 | 2017 | 213 | 0.800 |
Why?
| | Metalloproteases | 1 | 2022 | 43 | 0.780 |
Why?
| | Crystallography, X-Ray | 12 | 2025 | 476 | 0.720 |
Why?
| | Immunoglobulin A | 1 | 2022 | 211 | 0.710 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 109 | 0.660 |
Why?
| | Protease Inhibitors | 1 | 2020 | 107 | 0.660 |
Why?
| | Bacteria | 4 | 2023 | 858 | 0.650 |
Why?
| | Catalysis | 12 | 2024 | 307 | 0.630 |
Why?
| | Magnetic Resonance Spectroscopy | 9 | 2019 | 611 | 0.570 |
Why?
| | Erythrocytes | 5 | 2021 | 700 | 0.560 |
Why?
| | Binding Sites | 10 | 2021 | 1303 | 0.540 |
Why?
| | Protein Structure, Tertiary | 7 | 2015 | 861 | 0.530 |
Why?
| | Geobacillus | 2 | 2015 | 2 | 0.520 |
Why?
| | Valine | 1 | 2017 | 82 | 0.520 |
Why?
| | Immune Tolerance | 1 | 2019 | 363 | 0.510 |
Why?
| | Protein Structure, Secondary | 8 | 2017 | 374 | 0.500 |
Why?
| | RNA | 1 | 2023 | 921 | 0.500 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 99 | 0.500 |
Why?
| | Protein Folding | 5 | 2017 | 280 | 0.490 |
Why?
| | Energy Metabolism | 3 | 2021 | 922 | 0.490 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 162 | 0.480 |
Why?
| | Hemorrhagic Fever Virus, Crimean-Congo | 1 | 2015 | 4 | 0.460 |
Why?
| | Receptors, Interleukin-8A | 1 | 2014 | 6 | 0.440 |
Why?
| | Interleukin-8 | 2 | 2020 | 268 | 0.430 |
Why?
| | Recombinant Proteins | 8 | 2025 | 1353 | 0.430 |
Why?
| | Peptide Hydrolases | 1 | 2015 | 111 | 0.430 |
Why?
| | Pneumococcal Infections | 2 | 2025 | 115 | 0.420 |
Why?
| | Immunity, Innate | 2 | 2019 | 828 | 0.410 |
Why?
| | Peptides | 4 | 2014 | 985 | 0.410 |
Why?
| | Extracellular Space | 1 | 2013 | 119 | 0.400 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 132 | 0.400 |
Why?
| | Humans | 54 | 2025 | 137585 | 0.390 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 165 | 0.390 |
Why?
| | Allosteric Regulation | 3 | 2024 | 97 | 0.380 |
Why?
| | Temperature | 2 | 2012 | 679 | 0.380 |
Why?
| | Protein Domains | 4 | 2025 | 289 | 0.370 |
Why?
| | Interleukin-6 | 3 | 2021 | 778 | 0.370 |
Why?
| | Blood Preservation | 3 | 2021 | 285 | 0.370 |
Why?
| | Peptidylprolyl Isomerase | 4 | 2017 | 11 | 0.370 |
Why?
| | Oxidative Stress | 4 | 2025 | 1317 | 0.360 |
Why?
| | Structure-Activity Relationship | 4 | 2018 | 570 | 0.340 |
Why?
| | Enzyme Inhibitors | 3 | 2025 | 840 | 0.330 |
Why?
| | Interleukin-13 | 2 | 2001 | 149 | 0.330 |
Why?
| | Interleukins | 3 | 2023 | 250 | 0.330 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 2 | 2021 | 22 | 0.330 |
Why?
| | Amino Acid Sequence | 10 | 2025 | 2139 | 0.320 |
Why?
| | Biocatalysis | 2 | 2020 | 56 | 0.300 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 938 | 0.300 |
Why?
| | Oxidation-Reduction | 4 | 2025 | 1060 | 0.290 |
Why?
| | Nucleocapsid Proteins | 2 | 2023 | 23 | 0.290 |
Why?
| | Animals | 21 | 2025 | 36940 | 0.280 |
Why?
| | Immunologic Factors | 2 | 2021 | 236 | 0.280 |
Why?
| | DNA Viruses | 1 | 2007 | 14 | 0.280 |
Why?
| | Escherichia coli Proteins | 2 | 2017 | 200 | 0.270 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 465 | 0.260 |
Why?
| | Mice | 15 | 2025 | 17787 | 0.260 |
Why?
| | Amino Acid Motifs | 2 | 2017 | 225 | 0.250 |
Why?
| | Substrate Specificity | 3 | 2017 | 372 | 0.250 |
Why?
| | Exercise Tolerance | 2 | 2019 | 279 | 0.250 |
Why?
| | Thrombopoiesis | 1 | 2025 | 8 | 0.240 |
Why?
| | Megakaryocytes | 1 | 2025 | 34 | 0.230 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 16 | 0.230 |
Why?
| | Anti-Inflammatory Agents | 3 | 2021 | 496 | 0.230 |
Why?
| | Allosteric Site | 1 | 2024 | 19 | 0.230 |
Why?
| | Trypsin | 1 | 2025 | 77 | 0.230 |
Why?
| | Cell Line | 5 | 2021 | 2847 | 0.230 |
Why?
| | Peptide Fragments | 2 | 2000 | 706 | 0.230 |
Why?
| | Receptors, Interleukin-1 | 3 | 2021 | 216 | 0.230 |
Why?
| | Viral Proteins | 1 | 2007 | 342 | 0.230 |
Why?
| | Ligands | 4 | 2019 | 664 | 0.230 |
Why?
| | Molecular Sequence Data | 7 | 2014 | 2900 | 0.230 |
Why?
| | Protein Multimerization | 2 | 2019 | 192 | 0.220 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 2 | 2023 | 22 | 0.220 |
Why?
| | Haemophilus | 1 | 2024 | 7 | 0.220 |
Why?
| | Corynebacterium | 1 | 2024 | 49 | 0.220 |
Why?
| | Corynebacterium Infections | 1 | 2024 | 41 | 0.220 |
Why?
| | Enzyme Stability | 2 | 2015 | 70 | 0.220 |
Why?
| | Mammals | 2 | 2023 | 283 | 0.220 |
Why?
| | Antibodies, Monoclonal | 2 | 2021 | 1430 | 0.210 |
Why?
| | Acinetobacter baumannii | 1 | 2023 | 21 | 0.210 |
Why?
| | Haemophilus Infections | 1 | 2024 | 42 | 0.210 |
Why?
| | Haemophilus influenzae | 1 | 2024 | 63 | 0.210 |
Why?
| | Inflammation | 6 | 2021 | 2837 | 0.210 |
Why?
| | Nucleocapsid | 1 | 2023 | 19 | 0.210 |
Why?
| | Bacterial Adhesion | 2 | 2024 | 100 | 0.210 |
Why?
| | NAD | 1 | 2023 | 77 | 0.200 |
Why?
| | Amino Acids | 2 | 2017 | 497 | 0.200 |
Why?
| | Streptococcus | 1 | 2022 | 28 | 0.200 |
Why?
| | Blood Donors | 2 | 2021 | 105 | 0.190 |
Why?
| | Serine | 1 | 2023 | 141 | 0.190 |
Why?
| | Blood Banks | 2 | 2021 | 41 | 0.190 |
Why?
| | NADP | 2 | 2021 | 49 | 0.190 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 73 | 0.190 |
Why?
| | HEK293 Cells | 2 | 2021 | 730 | 0.180 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 192 | 0.180 |
Why?
| | Arginine | 1 | 2023 | 271 | 0.180 |
Why?
| | Kinetics | 5 | 2015 | 1670 | 0.180 |
Why?
| | Receptors, Interleukin | 1 | 2001 | 45 | 0.180 |
Why?
| | Receptors, Interleukin-18 | 1 | 2021 | 17 | 0.180 |
Why?
| | Spinal Cord | 2 | 2021 | 370 | 0.180 |
Why?
| | Protein Renaturation | 1 | 2000 | 4 | 0.180 |
Why?
| | Interleukin-3 | 1 | 2000 | 25 | 0.170 |
Why?
| | Cell Movement | 2 | 2017 | 967 | 0.170 |
Why?
| | Immune Evasion | 1 | 2021 | 58 | 0.170 |
Why?
| | Emergency Responders | 1 | 2021 | 36 | 0.170 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2000 | 51 | 0.170 |
Why?
| | Arthritis, Gouty | 1 | 2020 | 15 | 0.170 |
Why?
| | Cytokines | 3 | 2024 | 2085 | 0.170 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 28 | 0.170 |
Why?
| | Staphylococcus aureus | 1 | 2024 | 450 | 0.170 |
Why?
| | Isomerism | 2 | 2015 | 56 | 0.170 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 63 | 0.170 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 68 | 0.170 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 81 | 0.170 |
Why?
| | Staphylococcal Infections | 1 | 2024 | 400 | 0.160 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2000 | 137 | 0.160 |
Why?
| | Arthritis | 1 | 2020 | 95 | 0.160 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 76 | 0.160 |
Why?
| | Gout | 1 | 2020 | 37 | 0.160 |
Why?
| | Cryoelectron Microscopy | 1 | 2020 | 190 | 0.160 |
Why?
| | Interleukin-18 | 1 | 2021 | 236 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2020 | 185 | 0.160 |
Why?
| | Prescription Drugs | 1 | 2021 | 109 | 0.160 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 136 | 0.160 |
Why?
| | Complement C3d | 2 | 2010 | 67 | 0.160 |
Why?
| | Monocarboxylic Acid Transporters | 2 | 2017 | 22 | 0.160 |
Why?
| | Spliceosomes | 2 | 2017 | 48 | 0.150 |
Why?
| | Receptors, Complement 3d | 2 | 2010 | 141 | 0.150 |
Why?
| | Asparagine | 1 | 2018 | 31 | 0.150 |
Why?
| | Aspartic Acid | 1 | 2018 | 79 | 0.150 |
Why?
| | Static Electricity | 3 | 2014 | 118 | 0.150 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2018 | 16 | 0.150 |
Why?
| | Antibodies, Neutralizing | 1 | 2021 | 286 | 0.150 |
Why?
| | Intestinal Mucosa | 1 | 2023 | 623 | 0.140 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1998 | 13 | 0.140 |
Why?
| | Interleukin-17 | 1 | 2018 | 119 | 0.140 |
Why?
| | Glucose | 2 | 2021 | 1020 | 0.140 |
Why?
| | Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2017 | 11 | 0.140 |
Why?
| | Psoriasis | 1 | 2018 | 102 | 0.140 |
Why?
| | Models, Chemical | 3 | 2016 | 263 | 0.140 |
Why?
| | Cell Line, Tumor | 2 | 2017 | 3412 | 0.140 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 11 | 0.130 |
Why?
| | Endothelial Cells | 2 | 2019 | 785 | 0.130 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2017 | 17 | 0.130 |
Why?
| | Tyrosine | 1 | 1998 | 222 | 0.130 |
Why?
| | Nitrogen Isotopes | 3 | 2012 | 72 | 0.130 |
Why?
| | Spinal Cord Injuries | 1 | 2020 | 212 | 0.130 |
Why?
| | Gene Expression | 2 | 2025 | 1502 | 0.130 |
Why?
| | Point Mutation | 2 | 2009 | 235 | 0.130 |
Why?
| | Protein Structure, Quaternary | 3 | 2011 | 128 | 0.130 |
Why?
| | Proteolysis | 1 | 2017 | 177 | 0.120 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 150 | 0.120 |
Why?
| | RNA Splicing | 1 | 2017 | 269 | 0.120 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 156 | 0.120 |
Why?
| | Molecular Chaperones | 1 | 2017 | 195 | 0.120 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 283 | 0.120 |
Why?
| | Tumor Burden | 1 | 2017 | 309 | 0.120 |
Why?
| | Structural Homology, Protein | 1 | 2015 | 27 | 0.120 |
Why?
| | Cell Adhesion | 1 | 2017 | 466 | 0.120 |
Why?
| | Hemorrhagic Fever, Crimean | 1 | 2015 | 4 | 0.120 |
Why?
| | Mice, Nude | 1 | 2017 | 698 | 0.120 |
Why?
| | RNA Interference | 1 | 2017 | 469 | 0.120 |
Why?
| | Calcium Signaling | 1 | 2017 | 249 | 0.110 |
Why?
| | Ubiquitin | 1 | 2015 | 70 | 0.110 |
Why?
| | Transfection | 1 | 2017 | 945 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4295 | 0.110 |
Why?
| | Histidine | 1 | 2014 | 64 | 0.110 |
Why?
| | alpha-Synuclein | 1 | 2014 | 35 | 0.110 |
Why?
| | Cold Temperature | 1 | 2015 | 179 | 0.110 |
Why?
| | Signal Transduction | 3 | 2022 | 5079 | 0.110 |
Why?
| | Proline | 1 | 2014 | 79 | 0.110 |
Why?
| | Metabolome | 1 | 2017 | 350 | 0.100 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5757 | 0.100 |
Why?
| | Feedback, Physiological | 1 | 2013 | 77 | 0.100 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2018 | 804 | 0.100 |
Why?
| | Escherichia coli | 3 | 2025 | 815 | 0.100 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2014 | 172 | 0.100 |
Why?
| | Hydrogen | 1 | 2012 | 70 | 0.100 |
Why?
| | HIV-1 | 3 | 2010 | 864 | 0.090 |
Why?
| | Carbon Isotopes | 1 | 2012 | 144 | 0.090 |
Why?
| | Capsid Proteins | 2 | 2010 | 94 | 0.090 |
Why?
| | Lipopolysaccharides | 3 | 2021 | 886 | 0.090 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1092 | 0.090 |
Why?
| | Protein Transport | 1 | 2013 | 445 | 0.090 |
Why?
| | Aged | 5 | 2022 | 23961 | 0.090 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 1272 | 0.090 |
Why?
| | Mice, Transgenic | 3 | 2021 | 2167 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 455 | 0.090 |
Why?
| | Capsid | 2 | 2002 | 93 | 0.090 |
Why?
| | Metabolomics | 3 | 2021 | 678 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1396 | 0.090 |
Why?
| | Sequence Homology, Amino Acid | 3 | 2020 | 385 | 0.080 |
Why?
| | Up-Regulation | 1 | 2013 | 843 | 0.080 |
Why?
| | Receptors, IgE | 1 | 2010 | 45 | 0.080 |
Why?
| | Aging | 1 | 2021 | 1864 | 0.080 |
Why?
| | Hydrogen Bonding | 3 | 2009 | 163 | 0.080 |
Why?
| | PII Nitrogen Regulatory Proteins | 1 | 2009 | 1 | 0.080 |
Why?
| | DNA Mutational Analysis | 1 | 2011 | 399 | 0.080 |
Why?
| | Multigene Family | 1 | 2010 | 198 | 0.080 |
Why?
| | Time Factors | 2 | 2018 | 6828 | 0.080 |
Why?
| | Syndecan-1 | 1 | 2009 | 38 | 0.080 |
Why?
| | Protein Denaturation | 2 | 2017 | 74 | 0.080 |
Why?
| | Primary Cell Culture | 2 | 2021 | 171 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2017 | 2475 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 712 | 0.080 |
Why?
| | Glycolysis | 2 | 2021 | 321 | 0.080 |
Why?
| | Circular Dichroism | 2 | 2017 | 149 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 198 | 0.080 |
Why?
| | Brain | 1 | 2021 | 2668 | 0.070 |
Why?
| | Models, Biological | 4 | 2021 | 1783 | 0.070 |
Why?
| | Parkinson Disease | 1 | 2014 | 493 | 0.070 |
Why?
| | Protein Engineering | 1 | 2009 | 97 | 0.070 |
Why?
| | Adenylate Kinase | 2 | 2005 | 26 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 2 | 2001 | 665 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 558 | 0.070 |
Why?
| | Protein Isoforms | 1 | 2009 | 404 | 0.070 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2007 | 54 | 0.070 |
Why?
| | Virion | 1 | 2007 | 93 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2010 | 287 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1724 | 0.070 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1276 | 0.060 |
Why?
| | Calorimetry | 2 | 2017 | 70 | 0.060 |
Why?
| | Pliability | 1 | 2005 | 46 | 0.060 |
Why?
| | Female | 8 | 2024 | 73304 | 0.060 |
Why?
| | Thrombopoietin | 1 | 2025 | 5 | 0.060 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2607 | 0.060 |
Why?
| | Phosphorylation | 2 | 2020 | 1759 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2017 | 560 | 0.060 |
Why?
| | Enzymes | 1 | 2005 | 67 | 0.060 |
Why?
| | Small Molecule Libraries | 1 | 2025 | 94 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2021 | 3015 | 0.050 |
Why?
| | Male | 9 | 2021 | 67762 | 0.050 |
Why?
| | Heme | 1 | 2024 | 78 | 0.050 |
Why?
| | Movement | 1 | 2005 | 278 | 0.050 |
Why?
| | Hydrolases | 1 | 2023 | 48 | 0.050 |
Why?
| | Deuterium | 1 | 2023 | 99 | 0.050 |
Why?
| | Organoids | 1 | 2023 | 112 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 382 | 0.050 |
Why?
| | Receptors, Interleukin-13 | 1 | 2001 | 2 | 0.050 |
Why?
| | Interleukin-13 Receptor alpha1 Subunit | 1 | 2001 | 3 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 53 | 0.050 |
Why?
| | Receptors, Interleukin-4 | 1 | 2001 | 16 | 0.050 |
Why?
| | Hematopoietic Stem Cells | 1 | 2025 | 406 | 0.050 |
Why?
| | Mathematics | 1 | 2002 | 103 | 0.050 |
Why?
| | Iron | 1 | 2024 | 313 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2020 | 3556 | 0.050 |
Why?
| | Blood Platelets | 1 | 2025 | 408 | 0.050 |
Why?
| | Glutathione Disulfide | 1 | 2021 | 33 | 0.040 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.040 |
Why?
| | Macrophage Activation Syndrome | 1 | 2021 | 22 | 0.040 |
Why?
| | Candida albicans | 1 | 2021 | 54 | 0.040 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 45 | 0.040 |
Why?
| | Maltose-Binding Proteins | 1 | 2000 | 12 | 0.040 |
Why?
| | Microspheres | 1 | 2021 | 137 | 0.040 |
Why?
| | Solutions | 1 | 2001 | 168 | 0.040 |
Why?
| | Arthritis, Rheumatoid | 1 | 2010 | 1167 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 165 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2001 | 343 | 0.040 |
Why?
| | Avian Sarcoma Viruses | 1 | 2000 | 4 | 0.040 |
Why?
| | Immunoassay | 1 | 2021 | 115 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2001 | 216 | 0.040 |
Why?
| | Endopeptidases | 1 | 2000 | 90 | 0.040 |
Why?
| | Disulfides | 1 | 2000 | 107 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 199 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 345 | 0.040 |
Why?
| | Hemolysis | 1 | 2021 | 206 | 0.040 |
Why?
| | Peritonitis | 1 | 2020 | 84 | 0.040 |
Why?
| | Motion | 1 | 2020 | 99 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2001 | 455 | 0.040 |
Why?
| | Homeostasis | 1 | 2023 | 621 | 0.040 |
Why?
| | Phosphotyrosine | 1 | 1999 | 39 | 0.040 |
Why?
| | Protein Sorting Signals | 1 | 1999 | 20 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 158 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 594 | 0.040 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2019 | 60 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2021 | 194 | 0.040 |
Why?
| | Uric Acid | 1 | 2020 | 163 | 0.040 |
Why?
| | Hemoglobins | 1 | 2021 | 353 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2020 | 810 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2024 | 1096 | 0.040 |
Why?
| | Titrimetry | 2 | 2009 | 12 | 0.040 |
Why?
| | Middle Aged | 4 | 2021 | 33479 | 0.040 |
Why?
| | Fructose-Bisphosphate Aldolase | 1 | 1998 | 9 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 230 | 0.040 |
Why?
| | Periplasm | 1 | 2017 | 13 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2020 | 372 | 0.040 |
Why?
| | Binding, Competitive | 1 | 1998 | 202 | 0.030 |
Why?
| | Ultracentrifugation | 1 | 2017 | 52 | 0.030 |
Why?
| | Protein Unfolding | 1 | 2017 | 31 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2021 | 789 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2111 | 0.030 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2017 | 34 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1998 | 229 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 87 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 16 | 0.030 |
Why?
| | Keratinocytes | 1 | 2018 | 249 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2000 | 739 | 0.030 |
Why?
| | NF-kappa B | 1 | 2021 | 691 | 0.030 |
Why?
| | Adult | 4 | 2021 | 37929 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2021 | 625 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 103 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 660 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 2017 | 534 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 84 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 653 | 0.030 |
Why?
| | Rabbits | 1 | 1998 | 794 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 771 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2017 | 193 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1242 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 246 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 493 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 197 | 0.030 |
Why?
| | Running | 1 | 2017 | 230 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 257 | 0.030 |
Why?
| | Buffers | 1 | 2014 | 56 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 86 | 0.030 |
Why?
| | Neutrophils | 1 | 2020 | 1238 | 0.030 |
Why?
| | Electrochemistry | 1 | 2014 | 78 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 59 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 114 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 625 | 0.030 |
Why?
| | Skin | 1 | 2018 | 752 | 0.030 |
Why?
| | Magnesium | 1 | 2014 | 156 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 307 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2020 | 4193 | 0.020 |
Why?
| | Proteomics | 1 | 2018 | 1111 | 0.020 |
Why?
| | Rats | 1 | 2020 | 5647 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2426 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4565 | 0.020 |
Why?
| | Lung | 1 | 2024 | 4060 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2828 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 21513 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2010 | 103 | 0.020 |
Why?
| | Adaptive Immunity | 1 | 2010 | 165 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2009 | 148 | 0.020 |
Why?
| | Spectrum Analysis, Raman | 1 | 2008 | 41 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7635 | 0.020 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2007 | 38 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2010 | 365 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2007 | 145 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 852 | 0.020 |
Why?
| | Isoenzymes | 1 | 2007 | 304 | 0.020 |
Why?
| | Computer Simulation | 1 | 2009 | 978 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2010 | 847 | 0.010 |
Why?
| | Water | 1 | 2008 | 460 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 13209 | 0.010 |
Why?
| | Stereoisomerism | 1 | 2002 | 96 | 0.010 |
Why?
| | Virulence | 1 | 2002 | 267 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2002 | 319 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2000 | 443 | 0.010 |
Why?
| | Models, Structural | 1 | 1999 | 40 | 0.010 |
Why?
| | Drug Design | 1 | 1999 | 167 | 0.010 |
Why?
|
|
Eisenmesser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|